Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

BOOST Pharma has appointed Hans Schambye as its new chief [...]

BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

Alto Neuroscience has strengthened its intellectual property position around its [...]

Syncromune has appointed Stephen Dale as chief medical officer, strengthening [...]

Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

Cinclus Pharma has partnered with Zentiva to commercialize and manufacture [...]